SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiomeOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the relationship between SARS-CoV-2 infection and the upper respiratory tract (URT) microbiome. Researchers compared the URT microbiome of adults infected with SARS-CoV-2 to that of uninfected adults. They also examined whether SARS-CoV-2 viral load was associated with features of the URT microbiome during COVID-19. The URT microbiome was characterized using 16S ribosomal RNA sequencing, and models examined alpha-diversity, beta-diversity, and bacterial taxa abundance.
Who was studied?
The study included 59 adults. Of these, 38 had confirmed, symptomatic, mild to moderate COVID-19, and 21 were asymptomatic, uninfected controls. SARS-CoV-2 viral load was measured by quantitative reverse transcription PCR in those with COVID-19. All main models were adjusted for age and sex.
What were the most important findings?
The observed species index, a measure of bacterial richness, was significantly higher in SARS-CoV-2-infected adults than in uninfected adults (beta coefficient = 7.53, 95% CI 0.17 to 14.89, P = .045). Differential abundance testing identified nine amplicon sequence variants that were significantly different across the comparisons performed. These findings indicate that SARS-CoV-2 infection status is associated with measurable shifts in URT bacterial community composition and richness.
What are the greatest implications of this study?
The findings suggest that SARS-CoV-2 infection and its viral load are linked to detectable changes in the upper respiratory tract microbiome. This raises the possibility that the URT microbiome could serve as a marker of infection or disease dynamics in COVID-19. Further research building on these associations could help clarify how the respiratory microbiome interacts with viral infection and whether it holds diagnostic or prognostic value.